Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-04 | New | $242,034 | $242,034 | Equity Only | 06b | SEC link |
| 2024-12-16 | Amended | $7,429,000 | $3,032,000 | Debt Only | 06b | SEC link |
| 2023-10-31 | New | $4,397,000 | $4,397,000 | Debt Only | 06b | SEC link |
| 2021-10-29 | New | $5,039,710 | $5,039,710 | Equity Only | 06b | SEC link |
| 2019-10-28 | New | $915,667 | $915,667 | Equity Only | 06b | SEC link |
| 2018-07-12 | New | $900,000 | $900,000 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Sundaresh Brahmasandra | Director |
| Mike Bress | Executive |
| Gilbert G Garcia | Director |
| Michael Partsch | Director |
| Lauren Tyra | Director |
| Steven Weinstein | Director |
| Tobias Zutz | Director, Executive |